Opgen Overview
Latest debt-to-equity ratio for Opgen: 0.02 — see history and peer comparisons.
Get informed when a big investor buys or sells
+ Follow0.02
Debt-to-Equity ratio measures a company's financial leverage by comparing its total debt to shareholder equity. A lower D/E ratio generally indicates a more financially stable company with less risk.
The latest debt-to-equity ratio for OPGN is 0.02. That is below the Healthcare sector average of 0.27. Investors often review this figure alongside Opgen's historical trend and sector peers before judging valuation or financial health.
Against Healthcare companies, OPGN currently prints 0.02 for debt-to-equity ratio, while the sector average sits near 0.27. That is roughly 91.1% below the sector mean. Large gaps often invite a closer look at Opgen's growth, margins, and balance sheet.
A debt-to-equity ratio of 0.02 for Opgen is not 'good' or 'bad' on its own. Compare it with the peer average (0.27) and with OPGN's multi-year chart on this page. Persistently elevated multiples need growth or quality to justify them; depressed multiples need a catalyst or evidence the business is misunderstood.
After noting OPGN's debt-to-equity ratio (0.02), review year-over-year change, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.
This page's peer comparison chart is the fastest way to stack Opgen's debt-to-equity ratio against similar Healthcare names. You can also browse sector and industry screens on Stockcircle for a broader set of Healthcare companies and their key multiples and fundamentals.
